Production of a platelet aggregation inhibitor, salmosin, by high cell density fermentation of recombinant Escherichia coli.

Optimal conditions for a high cell density fermentation were investigated in a recombinant Escherichia coli producing salmosin, a platelet aggregation inhibitor. The optimized carbon and nitrogen sources were glycerol 10 g/l, yeast extract 30 g/l, and bacto-tryptone 10 g/l, yielding the dry cell weight (DCW) of 10.61 g/l in a 500 ml flask culture. The late-stage induction with 1% L-arabinose in a 5 l jar fermentor showed the highest DCW of 65.70 g/l after 27 h of the fed-batch fermentation. Around 2,200 mg/l of the protein was expressed as an inclusion body that was then refolded to obtain the active salmosin of 96 mg/l. We also confirmed the inhibitory activity against platelet aggregation of the active salmosin from the high cell density fermentation.

[1]  K. Jeong,et al.  High-level production of a single chain antibody against anthrax toxin in Escherichia coli by high cell density cultivation , 2011, Bioprocess and biosystems engineering.

[2]  H. Park,et al.  Control of specific growth rate to enhance the production of a novel disintegrin, saxatilin, in recombinant Pichia pastoris. , 2010, Journal of bioscience and bioengineering.

[3]  J. Queiroz,et al.  Application of a fed-batch bioprocess for the heterologous production of hSCOMT in Escherichia coli. , 2009, Journal of microbiology and biotechnology.

[4]  D. Weliky,et al.  Isotopically labeled expression in E. coli, purification, and refolding of the full ectodomain of the influenza virus membrane fusion protein. , 2008, Protein expression and purification.

[5]  Nag-Jong Kim,et al.  Optimization of culture condition for the production of D-amino acid oxidase in a recombinant Escherichia coli , 2008 .

[6]  Lakshmi Narasu Mangamoori,et al.  Optimization of the downstream process for high recovery of rhG-CSF from inclusion bodies expressed in Escherichia coli , 2008 .

[7]  M. Eiteman,et al.  Overcoming acetate in Escherichia coli recombinant protein fermentations. , 2006, Trends in biotechnology.

[8]  S. Singh,et al.  Solubilization and refolding of bacterial inclusion body proteins. , 2005, Journal of bioscience and bioengineering.

[9]  W. You,et al.  The snake venom disintegrin salmosin induces apoptosis by disassembly of focal adhesions in bovine capillary endothelial cells. , 2003, Biochemical and biophysical research communications.

[10]  D. S. Kim,et al.  A novel disintegrin salmosin inhibits tumor angiogenesis. , 1999, Cancer research.

[11]  Y. Yun,et al.  Purification and molecular cloning of a platelet aggregation inhibitor from the snake (Agkistrodon halys brevicaudus) venom. , 1998, Thrombosis research.

[12]  P. Xiao,et al.  Effects of Panax notoginseng saponins on platelet aggregation in rats with middle cerebral artery occlusion or in vitro and on lipid fluidity of platelet membrane , 1998 .

[13]  Hang-Cheol Shin,et al.  Optimization of fusion proinsulin production by high cell-density fermentation of recombinantE. coli , 1997 .

[14]  B. Junker,et al.  Process optimization for large-scale production of TGF-α-PE40 in recombinant Escherichia coli: effect of medium composition and induction timing on protein expression , 1997, Journal of Industrial Microbiology and Biotechnology.

[15]  H. Blanch,et al.  Recombinant Protein Expression in High Cell Density Fed-Batch Cultures of Escherichia Coli , 1992, Bio/Technology.

[16]  C. Teng,et al.  Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. , 1991, Biochemical pharmacology.

[17]  Tur-Fu Huang,et al.  Disintegrins: A Family of Integrin Inhibitory Proteins from Viper Venoms , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[18]  J. Maraganore,et al.  Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function. , 1990, The Journal of biological chemistry.

[19]  R. Pitti,et al.  Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Mustard,et al.  Clinical pharmacology of platelets. , 1977, Blood.

[21]  L. Brieba,et al.  Purification, refolding and autoactivation of the recombinant cysteine proteinase EhCP112 from Entamoeba histolytica. , 2009, Protein expression and purification.

[22]  Sung-Yu Hong,et al.  Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration. , 2002, Thrombosis research.

[23]  L. Shi,et al.  Platelet aggregation inhibitor from Murraya euchrestifolia , 1998 .

[24]  Jin-Ho Seo,et al.  Fed-batch Fermentations of Recombinant Escherichia coli to Produce Bacillus macerans CGTase , 1997 .